The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in hepatocellular carcinoma patients. Median progression-free survival was 8.3 months with ...

Ivonescimab plus chemotherapy improved PFS by 40% compared to Tevimbra in advanced squamous NSCLC, with a median PFS of 11.14 months versus 6.9 months. The study demonstrated consistent PFS benefits ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The trial results ...

Share on Pinterest A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty Images A drug combination already used in ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

Combining enzalutamide with standard hormone therapy cut the risk of prostate cancer death by over 40% in a clinical trial The treatment targeted patients whose prostate cancer recurred aggressively ...

Breakthrough yield and device performance at high volume show team can scale company's large-format advanced packaging for customers' cutting-edge applications SINGAPORE, Oct. 15, 2025 /PRNewswire/ -- ...

David Duke Jr. - a 6'4 American combo guard - has signed with the Perth Wildcats for the remainder of the 2025-26 NBL season, the Wildcats confirmed on Friday. As originally reported by ESPN, Duke Jr.

The FDA has approved a combination of Pfizer’s Braftovi and Merck KGaA’s Erbitux for a form of untreated metastatic colorectal cancer, the first targeted drug regimen for this form of the disease.

Correspondence to Dr Patrick O McKeon, Department of Exercise and Sport Science, School of Health Sciences and Human Performance, Ithaca College Hill Center, Room G66 953 S. Danby Rd, Ithaca, NY 14850 ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. Despite the enthusiasm of ...